Dr. Melinda L Telli MD?
Update this Profile
Dr. Melinda L Telli MD, Internist
We verify the medical license of each FindaTopDoc Verified Doctor to ensure that their license is active and they are in good medical standing.

Dr. Melinda L Telli MD

Oncologist | Medical Oncology

875 Blake Wilbur Drive Mc 5820 Stanford CA, 94305
Write A Review

About

Dr. Melinda Telli is an oncologist practicing in Stanford, CA. Dr. Telli specializes in the care and treatment of patients with cancer. As an oncologist, Dr. Telli manages and oversees the treatment of a cancer patient after he or she has been diagnosed with the disease. Oncologists will care for their patients throughout the course of the disease. Types of oncologists include medical oncologists, surgical oncologists, radiation oncologists, gynecologic oncologists, pediatric oncologists and hematologist oncologists.

Board Certification

Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology

Internal MedicineAmerican Board of Internal MedicineABIM- 2005

Provider Details

FemaleEnglish

Expert Publications

Data provided by the National Library of Medicine

Clinical Trials

Awards

  • Susan G. Komen for the Cure 2012 Career Catalyst Research Award 
  • Stanford University School of Medicine 2010, 2010 Oncology Division Teaching Award 
  • American Society of Clinical Oncology 2009 Young Investigator Award 
  • Susan G. Komen for the Cure 2008 Fellowship Award 
  • American Society of Clinical Oncology 2008 Merit Award 
  • Stanford Cancer Institute 2011 New Investigator Award 

Treatments

  • General Care, Breast Cancer

Fellowships

  • Stanford University Medical Oncology    2008
  • Stanford University School of Medicine CA    2008
  • Stanford University School of Medicine,Stanford, Ca, United States   2008

Publications

  • JOURL OF CLINICAL ONCOLOGYInsight or confusion: survival after response-guided neoadjuvant chemotherapy in breast cancer2013
  • JOURL OF CLINICAL ONCOLOGYUnderestimating Cardiac Toxicity in Cancer Trials: Lessons Learned?2012
  • JOURL OF THE AMERICAN COLLEGE OF CARDIOLOGYLeft Ventricular Dysfunction in Patients Receiving Cardiotoxic Cancer Therapies Are Clinicians2010
  • ANLS OF ONCOLOGYCardiotoxicity associated with the cancer therapeutic agent sunitinib malate2008
  • JOURL OF CLINICAL ONCOLOGYTrastuzumab-related cardiotoxicity: Calling into question the concept of reversibility2007
  • Jourl of the American Medical Informatics AssociationDymic contrast-enhanced MRI2013
  • JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORKChest Wall Leiomyosarcoma After Breast-Conservative Therapy for Early2012
  • PLOS ONESingle Cell Profiling of Circulating Tumor Cells2012
  • ture and science of sleepPrevalence, putative mechanisms2012
  • JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORKTrastuzumab-Related Cardiac Dysfunction2011
  • JOURL OF CLINICAL ONCOLOGYIncreasing Mastectomy Rates for Early-Stage Breast Cancer? Population-Based Trends From California2010
  • Jourl of the tiol Comprehensive Cancer NetworkPhyllodes tumors of the breast: tural history, diagnosis, and treatment.2007
  • BIOCHEMICAL PHARMACOLOGYEpidermal growth factor1999
  • JOURNAL OF CLINICAL ONCOLOGYInsight or confusion: survival after response-guided neoadjuvant chemotherapy in breast cancer2013
  • JOURNAL OF CLINICAL ONCOLOGYUnderestimating Cardiac Toxicity in Cancer Trials: Lessons Learned?2012
  • LANCET ONCOLOGYPARP inhibitors in cancer: moving beyond BRCA2011
  • BREAST CANCER RESEARCH AND TREATMENTAsian ethnicity and breast cancer subtypes: a study from the California Cancer Registry2011
  • JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGYLeft Ventricular Dysfunction in Patients Receiving Cardiotoxic Cancer Therapies Are Clinicians2010
  • ANNALS OF ONCOLOGYCardiotoxicity associated with the cancer therapeutic agent sunitinib malate2008
  • JOURNAL OF CLINICAL ONCOLOGYTrastuzumab-related cardiotoxicity: Calling into question the concept of reversibility2007
  • Breast cancer research : BCRPatient-derived xenografts of triple2014
  • Radiology(18)F-FPPRGD2 PET/CT: Pilot Phase Evaluation of Breast Cancer Patients.2014
  • American Society of Clinical Oncology educational book / ASCO. AmericaOptimizing chemotherapy in triple-negative breast cancer: the role of platinum.2014
  • BMC cancerSingle cell mutational analysis of PIK3CA in circulating tumor cells2014
  • Journal of the American Medical Informatics AssociationDynamic contrast-enhanced MRI2013
  • BREAST CANCER RESEARCH AND TREATMENTA clinical trial of lovastatin for modification of biomarkers associated with breast cancer risk2013
  • AMIA Summits on Translational Science proceedings AMIA Summit on TransQualitative and quantitative image-based biomarkers of therapeutic response in triple2013
  • JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORKChest Wall Leiomyosarcoma After Breast-Conservative Therapy for Early2012
  • BREAST CANCER RESEARCH AND TREATMENTBreast cancer phenotype in women with TP53 germline mutations2012
  • PLOS ONESingle Cell Profiling of Circulating Tumor Cells2012
  • Nature and science of sleepPrevalence, putative mechanisms2012
  • HEART FAILURE CLINICSChemotherapy-Associated Cardiotoxicity: How Often Does it Really Occur and How Can it Be Prevented?2011
  • JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORKTrastuzumab-Related Cardiac Dysfunction2011
  • Clinical advances in hematology & oncology : H&OPARP inhibitors in breast cancer.2010
  • CLINICAL BREAST CANCERNovel Treatment Approaches for Triple-Negative Breast Cancer2010
  • JOURNAL OF CLINICAL ONCOLOGYIncreasing Mastectomy Rates for Early-Stage Breast Cancer? Population-Based Trends From California2010
  • CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTIONLonger Relative Telomere Length in Blood from Women with Sporadic2010
  • CLINICAL BREAST CANCERFirst-Line Chemotherapy for Metastatic Breast Cancer2009
  • Journal of the National Comprehensive Cancer NetworkPhyllodes tumors of the breast: natural history, diagnosis, and treatment.2007
  • BIOCHEMICAL PHARMACOLOGYEpidermal growth factor1999

Experience & Accolades

  • Assistant Professor of Medicine (Oncology)the Stanford University Medical Center
  • MemberScientific Program Committee, Triple Negative Breast Cancer/Cytotoxics/Local Therapy
  • Member2010 - 2013 American Society of Clinical Oncology
  • Member2010 - 2013 Program Committee, ASCO Breast Cancer Symposium

Dr. Melinda L Telli MD's Practice location

Melinda Telli

875 Blake Wilbur Drive Mc 5820 -
Stanford, CA 94305
Get Direction
New patients: 650-723-4000

Dr. Melinda L Telli MD's reviews

(0)
Write Review

Recommended Articles

  • Chemotherapy for Cervical Cancer

    What is chemotherapy?Chemotherapy is a form of cancer treatment that uses medicine to kill the cancer cells. The cancer cells are being damaged and killed so that they will not be able to reproduce and spread. It is usually used if there is a risk that cancer will spread or when it has already...

  • Is Testicular Cancer Hereditary?

    In testicular cancer, germ cells that populate the seminiferous tubules of the testes, and which are responsible for growing into matured sperm, seem to lose control and multiply without pause, creating a larger mass of tumorous tissue. Besides pain, swelling and fluid accumulation, testicular...

  • Holistic Treatments for Liver Cancer

    Holistic treatment for liver cancer indicates a science of healing that uses the person's whole spirit, mind and body. This treatment practice integrates the alternative and conventional therapies used to prevent and treat liver cancer, as well as promote the patient's wellbeing. The principle...

  • Prostate Cancer: What are the Different Medical Procedures for this Condition?

    Prostate cancer is one of the most common cancers among men. There are a number of ways to treat prostate cancer. Every method involves a process of decision making, support from friends and family, and understanding side effects that result from the treatments and dealing with them.Men with...

  • False-Positive Mammograms May Predict the Risk for Breast Cancer

    According to a new study published in the Journal of the National Cancer Institute, about 50% of women who get annual mammograms may have at least one false positive reading, and these women may have a higher risk of developing breast cancer. In this study, conducted by Danish researchers, women...

  • Can I Live Without a Bladder if I Have Bladder Cancer?

    The bladder is the organ in the human body that stores urine temporarily to be released later through the urethra. It is, therefore, a very important part of the body. Unfortunately, in some cases of bladder cancer, the bladder has to be removed.The removal of the urinary bladder is done through a...

Nearby Providers

See all nearby providers

Nearest Hospitals

LUCILE SALTER PACKARD CHILDREN'S HSP AT STANFORDl

725 WELCH ROAD PALO ALTO CA 94304

Head north on Blake Wilbur Drive 357 ft
Turn right onto Welch Road 788 ft
Turn right 348 ft
Turn left 69 ft
You have arrived at your destination, on the left

1562 ftSee direction

STANFORD HEALTH CAREl

300 PASTEUR DRIVE STANFORD CA 94305

Head north on Blake Wilbur Drive 383 ft
Turn left onto Welch Road 1270 ft
Turn left onto Pasteur Drive 55 ft
You have arrived at your destination, on the left

1708 ftSee direction

MENLO PARK SURGICAL HOSPITALl

570 WILLOW ROAD MENLO PARK CA 94025

Head north on Blake Wilbur Drive 357 ft
Turn right onto Welch Road 1607 ft
Turn left onto Quarry Road 1048 ft
Turn right onto Arboretum Road 1357 ft
Turn left onto Palm Drive 1622 ft
Continue straight onto University Avenue 851 ft
Continue onto University Avenue 3088 ft
Turn left onto Middlefield Road 2535 ft
Turn right onto Willow Road 3026 ft
Turn right 219 ft
You have arrived at your destination, on the right

3.0 miSee direction